Exposure to thimerosal in vaccines used in Canadian infant immunization programs, with respect to risk of neurodevelopmental disorders.

Canada communicable disease report = Relevé des maladies transmissibles au Canada

Volumn 28, Issue 9, 2002, Pages 69-80

  Bigham, M ^a   Copes, R ^a   Srour, L ^a  

^a BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE; MERCURY; PRESERVATIVE; THIOMERSAL;

AUTISM; CHEMICALLY INDUCED DISORDER; CHEMISTRY; ENVIRONMENTAL EXPOSURE; HUMAN; NEUROLOGIC DISEASE; REVIEW; RISK FACTOR;

AUTISTIC DISORDER; ENVIRONMENTAL EXPOSURE; HEPATITIS B VACCINES; HUMANS; MERCURY; NERVOUS SYSTEM DISEASES; PRESERVATIVES, PHARMACEUTICAL; RISK FACTORS; THIMEROSAL;

EID: 0036583296     PISSN: 11884169     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (54)